QOL Similar With Checkpoint Combo Versus Single-Agent Immunotherapy in Melanoma
May 31st 2016Patients with melanoma who were treated with a combination of Opdivo and Yervoy showed no significant changes in their quality of life when compared to those who were treated with either agent alone.
Read More